United Therapeutics
UTHR
UTHR
360 hedge funds and large institutions have $4.6B invested in United Therapeutics in 2018 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 108 increasing their positions, 139 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
360
Holders Change
-6
Holders Change %
-1.64%
% of All Funds
8.03%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
44
Increased
108
Reduced
139
Closed
49
Calls
$6.3M
Puts
$9.31M
Net Calls
-$3.02M
Net Calls Change
-$6.22M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$27.5M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$26M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$20.4M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$15.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$14.6M |
Top Sellers
| 1 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$40.9M |
| 2 |
AC
Armistice Capital
New York
|
-$37.3M |
| 3 |
Goldman Sachs
New York
|
-$21.6M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$15.5M |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$14.7M |
